SIGNALAI·Jun 2, 2026, 4:00 AMSignal75Short term

AutoForest: Automatically Generating Forest Plots from Biomedical Studies with End-to-End Evidence Extraction and Synthesis

Source: arXiv cs.CL

Share
AutoForest: Automatically Generating Forest Plots from Biomedical Studies with End-to-End Evidence Extraction and Synthesis

arXiv:2606.02403v1 Announce Type: new Abstract: Systematic reviews rely on forest plots to synthesise quantitative evidence across biomedical studies, but generating them remains a fragmented and labour-intensive process. Researchers must interpret complex clinical texts, manually extract outcome data from trials, define appropriate interventions and comparators, harmonise inconsistent study designs, and carry out meta-analytic computations-typically using specialised software that demands structured inputs and domain expertise. While recent work has demonstrated that large language models can

Why this matters
Why now

The development of advanced large language models (LLMs) has matured to a point where they can be applied to complex, labor-intensive tasks in scientific research, such as evidence extraction and synthesis.

Why it’s important

This development signifies a significant advancement in automating scientific discovery and review processes, potentially accelerating biomedical research and reducing human error and resource allocation in systematic reviews.

What changes

The fragmented and manual process of generating forest plots from biomedical studies can now be significantly automated, shifting the paradigm of systematic evidence synthesis.

Winners
  • · Biomedical researchers
  • · Pharmaceutical companies
  • · AI/ML developers
  • · Medical institutions
Losers
  • · Manual data extractors
  • · Traditional meta-analysis software vendors
  • · Workflows reliant on extensive human review
Second-order effects
Direct

Systematic reviews become significantly faster and more scalable, leading to more frequent updates and broader coverage of medical literature.

Second

The increased efficiency and accuracy in synthesising evidence could lead to quicker identification of effective treatments and more robust clinical guidelines.

Third

This automation could free up research time for more novel experimentation and hypothesis generation, accelerating the pace of biomedical innovation and drug discovery.

Editorial confidence: 90 / 100 · Structural impact: 60 / 100
Original report

This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.

Read at arXiv cs.CL
Tracked by The Continuum Brief · live intelligence network
Share
The Brief · Weekly Dispatch

Stay ahead of the systems reshaping markets.

By subscribing, you agree to receive updates from THE CONTINUUM BRIEF. You can unsubscribe at any time.